教員別検索
所属別検索
学位論文・関西医大誌
学術雑誌掲載論文
学会発表
（最終更新日：2026-07-13 11:23:20）
ヨシムラ ヒデアキ
YOSHIMURA HIDEAKI
吉村 英晃
所属
医学部内科学第一講座
職種
助教
■
学術雑誌掲載論文
1.
原著(症例報告除く)
左房粘液腫に合併し外科的切除のみで寛解を維持したフィブリン関連大細胞型B細胞リンパ腫 2026/04
2.
原著(症例報告除く)
Real-World Outcomes of Polatuzumab Vedotin Plus R-CHP Versus R-CHOP-Based Regimens in Japanese Patients With Untreated Diffuse Large B-Cell Lymphoma. 2026/01
3.
原著(症例報告除く)
Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease 2024/04
4.
原著(症例報告除く)
Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft-versus-host disease by inhibiting T-cell migration to the gastrointestinal tract 2022/09
5.
原著(症例報告除く)
Real-world efficacy of letermovir prophylaxis for cytomegaloviru infections after allogeneic hematopoietic stem cell transplantations: A single-center retrospective analysis 2022/09
6.
原著(症例報告除く)
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation 2021/08
7.
原著(症例報告除く)
Multiple Myeloma with Central Nervous System Relapse Early after Autologous Stem Cell Transplantation: A Case Report and Literature Review 2021
8.
原著(症例報告除く)
Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis 2020/12
9.
症例報告
Refractory Chronic Lymphocytic Leukemia with
Central Nervous System Involvement: A Case
Report with Literature Review 2020/12
10.
原著(症例報告除く)
Comparison of Starting Doses of Anagrelide as a First-Line Therapy in Patients With Cytoreductive Therapy-Naïve Essential Thrombocythemia: Difference Between Starting at 0.5 and 1.0 Mg/Day 2020/07
11.
原著(症例報告除く)
Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical setting. 2020/02
12.
原著(症例報告除く)
Effect of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation 2019/12
13.
原著(症例報告除く)
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation. 2019/12
14.
症例報告
Intravascular Large B-Cell Lymphoma; Our Experience with the Disease at Two Medical Centers 2019/12
15.
原著(症例報告除く)
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era. 2019/12
16.
症例報告
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms. 2019/09
17.
原著(症例報告除く)
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting. 2019/08
18.
その他
Efficacy of CMV prophylaxis with letermovir early after transplantation. 2019/07
19.
原著(症例報告除く)
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma. 2019/05
20.
原著(症例報告除く)
Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in Japan. 2019/05
21.
原著(症例報告除く)
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience. 2019/03
22.
症例報告
Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia. 2019/03
23.
原著(症例報告除く)
GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells. 2019/01
24.
原著(症例報告除く)
Induction of PIR-A/B(+) DCs in the in vitro inflammatory condition and their immunoregulatory function. 2018/10
25.
原著(症例報告除く)
Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia. 2018/09
26.
原著(症例報告除く)
Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study. 2018/08
27.
その他
自家末梢血幹細胞移植後のbrentuximab vedotin維持療法が奏効した高リスクHodgkinリンパ腫 2018/08
28.
原著(症例報告除く)
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide. 2018/07
29.
原著(症例報告除く)
Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia. 2018/05
30.
原著(症例報告除く)
Human T-cell Leukemia Virus Type I Associated with an Increased Risk of Primary Malignant Neoplasm. 2018/04
31.
原著(症例報告除く)
How to select Tyrosine Kinase Inhibitor for the patients with newly diagnosed Chronic Myeloid Leukemia? 2018
32.
症例報告
Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma 2018
33.
症例報告
Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection. 2017/12
34.
原著(症例報告除く)
胃癌を合併しATRAでコントロール良好となったAPL再発の一例 2017/12
35.
原著(症例報告除く)
腰部脊柱管狭窄症の手術を実施したITP症例 2017/12
36.
原著(症例報告除く)
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case report 2017/11
37.
原著(症例報告除く)
Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphoma 2017/09
38.
症例報告
治療抵抗性のITPに対し悪性リンパ腫の関与が疑われた一症例 2014/12
39.
原著(症例報告除く)
Recombinant thrombomodulin reduces the elevation of PAI-1 after allogeneic hematopoietic stem cell transplantation. 2013/02
40.
症例報告
血球貪食症候群を繰り返しDICを発症したNK/Tリンパ腫の一例 2013/02
41.
その他
骨髄異形成症候群と赤血球輸血 2013/02
42.
その他
TGFβ(1) and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP. 2012/09
43.
その他
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation. 2012/07
5件表示
全件表示(43件)
